Aviva’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-124,757
Closed -$26.5M 856
2014
Q4
$26.5M Sell
124,757
-490
-0.4% -$97.4K 0.21% 112
2014
Q3
$22.3M Sell
125,247
-680
-0.5% -$113K 0.18% 133
2014
Q2
$21.3M Sell
125,927
-660
-0.5% -$103K 0.16% 157
2014
Q1
$15.7M Sell
126,587
-12,056
-9% -$1.47M 0.13% 191
2013
Q4
$15.4M Sell
138,643
-25,606
-16% -$2.45M 0.13% 189
2013
Q3
$14.9M Buy
164,249
+73,526
+81% +$6.6M 0.13% 194
2013
Q2
$7.64M Buy
+90,723
New +$9.41M 0.08% 270

Other funds holding AGN

Aviva's AGN Position: Q1 2015 in Review

Aviva sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 124,757 shares — an estimated $26.5M sold.

Aviva first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $26.5M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Aviva reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Aviva sold 124,757 Allergan Inc shares in Q1 2015, an estimated $26.5M.
  • Aviva first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Aviva's Allergan Inc position peaked at $26.5M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Aviva's 13F filing for Q1 2015, filed 14 May 2015.